News from the FDA/CDC

FDA approves nivolumab for advanced squamous cell carcinoma of the head and neck

Publish date: November 11, 2016

The agency based its approval on an improvement in overall survival shown in the CheckMate-141 trial, which compared nivolumab with the...

Publish date: November 5, 2016

The CDC has reported seven cases of the multidrug-resistant fungal infection Candida auris in the United States, all in health care settings.

Publish date: October 25, 2016

Pembrolizumab (Keytruda) is now approved to treat patients with metastatic NSCLC whose tumors have high PD-L1 expression, with no EGFR or ALK...

Publish date: October 20, 2016

The FDA has approved the PD-L1 blocking antibody atezolizumab for the treatment of patients with metastatic non–small-cell lung cancer whose...

Publish date: October 20, 2016

Olaratumab, a platelet-derived growth factor receptor-alpha blocking antibody, is the first new therapy approved in 40 years for the initial...

Publish date: October 5, 2016

Physicians had the highest level of coverage (95.6%), while health care assistants and aides had the lowest (64.5%).